A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Active, not recruiting · NCT02381886 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, acute myeloid leukemia, adenocarcinoma, astrocytoma (excluding glioblastoma), bone marrow disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, glioblastoma, glioma, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm, neuroepithelial neoplasm, oligodendroglioma, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2026-04-13 | NCT02381886 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Medical center | New York | United States | 224 |
| Columbia University Medical Center- New York Presbyterian Onc Dept. | New York | United States | 1 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Dana Farber Cancer Institute SC (1) | Boston | United States | 1 |
| ErasmusMC Cancer lnstitute, Neuro-Oncology, Rm G3-55 | Rotterdam | Netherlands | 1 |
| Uni Of TX MD Anderson Cancer Cntr | Houston | United States | 7 |